Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRB1 | P17538 | 5/20 | 0.58 |
| ▸ | ELANE | P08246 | 5/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | PTGFR | P43088 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.34 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6639306 | 0.93 | ELANE (0.60) | CTRB1ELANE | |
| SCHEMBL6637784 | 0.92 | ELANE (0.61) | CTRB1ELANEKDM4ETDP1PTGFR | |
| SCHEMBL6637727 | 0.89 | ELANE (0.57) | CTRB1ELANEKDM4ETDP1PTGFR | |
| SCHEMBL6637731 | 0.89 | ELANE (0.57) | CTRB1ELANEKDM4ETDP1PTGFR | |
| SCHEMBL6636428 | 0.87 | ELANE (0.57) | CTRB1ELANE | |
| SCHEMBL6640343 | 0.87 | CTRB1 (0.55) | CTRB1ELANEKDM4ETDP1PTGFR | |
| SCHEMBL6635434 | 0.86 | ELANE (0.56) | CTRB1ELANE | |
| SCHEMBL6634622 | 0.86 | CTRB1 (0.56) | CTRB1ELANEKDM4ETDP1PTGFR | |
| SCHEMBL6635359 | 0.86 | ELANE (0.55) | CTRB1ELANEKDM4ETDP1PTGFR | |
| SCHEMBL6641428 | 0.85 | CTRB1 (0.52) | CTRB1ELANEKDM4ETDP1PTGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040116420-A1 | Remedial agent for viral infectious disease | ASAHI KASEI PHARMA CORPORATION (JP) | 2004-06-17 | — | — | US | disclosed |